284
F. Effenberger, S. Oßwald / Tetrahedron: Asymmetry 12 (2001) 279–285
tration, (R)-amides
petroleum ether/chloroform. The amides 5d,e, required
as reference compounds, were prepared analogously.
5
were recrystallized from
CHCl3), e.e.=98%. NMR data correspond to those of
racemic 4c.
3.8.3. (R)-2-Fluoro-2-(3-methoxyphenyl)acetic acid (R)-
4f. White needles; mp 67–69°C; [h]2D0=+154.0 (c 1.0,
3.7.1. (R)-2-Fluoro-2-phenylacetamide (R)-5a. White
needles; mp 144–145°C; [h]2D0=+122.3 (c 0.9, CHCl3),
e.e.=>99%. 1H NMR (500 MHz, DMSO-d6): l 5.76 (d,
J=48.4 Hz, 1H), 6.26, 6.47 (br s each, 2H), 7.46–7.48
(m, 5H). Anal. calcd for C8H8FNO (153.2): C, 62.74;
H, 5.26; N, 9.15. Found: C, 62.61; H, 5.27; N, 9.14%.
1
CHCl3), e.e.=>99%. H NMR (500 MHz): l 3.77 (s,
3H), 5.95 (d, J=47.6 Hz, 1H), 6.99–7.38 (m, 4H), 13.50
(br s, 1H). Anal. calcd for C9H9FO3 (184.2): C, 58.70;
H, 4.93. Found: C, 58.91; H, 4.98%.
3.7.2. (R)-2-Fluoro-2-(3-methylphenyl)acetamide (R)-5c.
White needles; mp 125–126°C; [h]2D0=+107.3 (c 0.7,
Acknowledgements
1
CHCl3), e.e.=97%. H NMR (500 MHz, DMSO-d6): l
2.32 (s, 3H), 5.73 (d, J=48.1 Hz, 1H), 7.21–7.31 (m,
4H), 7.56, 7.85 (br s each, 2H). Anal. calcd for
C9H10FNO (167.2): C, 64.66; H, 6.03; N, 8.38. Found:
C, 64.50; H, 6.00; N, 8.36%.
We would like to thank the Bundesministerium fu¨r
Bildung und Forschung (Zentrales Schwerpunktpro-
gramm Bioverfahrenstechnik, Stuttgart) and the Fonds
der Chemischen Industrie for financial support. We
acknowledge Dr. H. Wajant for cloning the enzyme,
Dr. S. Fo¨rster for fermentations, and Dr. A. Baro for
preparing the manuscript.
3.7.3. 2-Fluoro-2-(4-methylphenyl)acetamide 5d. Mp
1
140–141°C. H NMR (250 MHz, DMSO-d6): l 2.31 (s,
3H), 5.73 (d, J=48.2 Hz, 1H), 7.21–7.35 (m, 4H), 7.57,
7.86 (br s each, 2H). Anal. calcd for C9H10FNO (167.2):
C, 64.66; H, 6.03; N, 8.38. Found: C, 64.56; H, 6.07; N,
8.35%.
References
1. Enzyme catalyzed reactions, Part 40. Part 39: Bu¨hler, H.;
Bayer, A.; Effenberger, F. Chem. Eur. J. 2000, 6, 2564–
2571.
2. Gerstenberger, M. R. C.; Haas, A. Angew. Chem. 1981,
93, 659–680; Angew. Chem., Int. Ed. Engl. 1981, 20,
647–668.
3.7.4. 2-Fluoro-2-(4-nitrophenyl)acetamide 5e. Mp 111–
113°C. 1H NMR (500 MHz, DMSO-d6): l 5.73 (d,
J=48.2 Hz, 1H), 7.22–8.31 (m, 4H), 7.71, 8.02 (br s
each, 2H). HRMS calcd for C8H7FN2O3 (M+)
198.0441. Found: 198.0443.
3. Welch, J. T. Tetrahedron 1987, 43, 3123–3197.
4. Mann, J. Chem. Soc. Rev. 1987, 16, 381–436.
5. Bravo, P.; Resnati, G. Tetrahedron: Asymmetry 1990, 1,
661–692.
6. Khrimian, A. P.; Oliver, J. E.; Waters, R. M.; Panicker,
S.; Nicholson, J. M.; Klun, J. A. Tetrahedron: Asymmetry
1996, 7, 37–40.
7. Kokuryo, Y.; Kawata, K.; Nakatani, T.; Kugimiya, A.;
Tamura, Y.; Kawada, K.; Matsumoto, M.; Suzuki, R.;
Kuwabara, K.; Hori, Y.; Ohtani, M. J. Med. Chem. 1997,
40, 3280–3291.
3.7.5. (R)-2-Fluoro-2-(3-methoxyphenyl)acetamide (R)-
5f. White needles; mp 89–90°C; [h]2D0=+141.8 (c 1.0,
1
CHCl3), e.e.=>99%. H NMR (250 MHz, DMSO-d6):
l 3.73 (s, 3H), 5.76 (d, J=48.0 Hz, 1H), 6.95–7.56 (m,
4H), 7.56, 7.86 (br s each, 2H). Anal. calcd for
C9H10FNO2 (183.2): C, 59.01; H, 5.50; N, 7.65. Found:
C, 59.10; H, 5.63; N, 7.45%.
3.8. Acid hydrolysis of (R)-2-fluoroamides 5a,c and f to
(R)-2-fluoroacetic acids 4a,c and f; general procedure
8. Chandrakumar, N. S.; Yonan, P. K.; Stapelfeld, A.;
Savage, M.; Rorbacher, E.; Contreras, P. C.; Hammond,
D. J. Med. Chem. 1992, 35, 223–233.
9. (a) Kalaritis, P.; Regenye, R. W. Org. Synth., Coll. Vol. 8
1993, 258–262; (b) Tranel, F.; Haufe, G. Tetrahedron:
Asymmetry 2000, 11, 889–896.
10. (a) LeTourneau, M. E.; McCarthy, J. R. Tetrahedron
Lett. 1984, 25, 5227–5230; (b) Stelzer, U.; Effenberger, F.
Tetrahedron: Asymmetry 1993, 4, 161–164.
11. Kobayashi, M.; Shimizu, S. FEMS Microbiol. Lett. 1994,
120, 217–224.
12. Yamamoto, K.; Fujimatsu, I.; Komatsu, K. J. Ferment.
Bioeng. 1992, 73, 425–430.
Amide 5a,c or f (0.82–1.31 mmol) was suspended in a
10% solution of sulfuric acid (25 mL/100 mg 5). The
vigorously stirred reaction mixture was heated at 60°C
for 3 h, and extracted twice with the double volume of
diethyl ether. The corresponding acid 4 was extracted
from the organic phase with a sat. NaHCO3 solution
(1/10 volume of the organic phase). The aqueous phase
was acidified to pH 4 and extracted with the double
volume of diethyl ether. The combined extracts were
dried (Na2SO4) and concentrated. Acids 4 were recrys-
tallized from petroleum ether/chloroform.
3.8.1. (R)-2-Fluoro-2-phenylacetic acid (R)-4a. White
needles; mp 104°C; [h]D20=+150.3 (c 1.0, CHCl3), e.e.=
>99%. [h]2D0=+71.4 (c 1.25, CHCl3), e.e.=46%.19 NMR
data correspond to those of racemic 4a.
13. Nagasawa, T.; Mauger, J.; Yamada, H. Eur. J. Biochem.
1990, 194, 765–772.
14. Layh, N.; Parratt, J.; Willetts, A. J. Mol. Catal. B:
Enzym. 1998, 5, 467–474.
15. Bartling, D.; Seedorf, M.; Mitho¨fer, A.; Weiler, E. W.
3.8.2. (R)-2-Fluoro-2-(3-methylphenyl)acetic acid (R)-4c.
White needles; mp 83–84°C; [h]2D0=+137.4 (c 1.0,
Eur. J. Biochem. 1992, 205, 417–424.
16. Oßwald, S. Dissertation, Universita¨t Stuttgart, 2000.